Hans SöderlundChairman of the Board
Hans is one of the founders of Desentum and a member of the board. He has a long experience in molecular biology and biotechnology.
After 10 years in academia Hans moved to a Finnish health care company Orion Pharma to set up a biotechnology unit for drug discovery and molecular diagnostics. In 1991 he joined the Technical Research Centre of Finland (VTT), first to act as a professor in genetic engineering, and later the vice president, strategic research. Currently, he is the chairman of the board of the University of Oulu, and a board member in Paras Biopharmaceuticals, a Finnish biotech company specialized in production technologies for peptide hormones.
Hans holds a PhD in biochemistry from the University of Helsinki.